PotBotics Inc, which operates as RYAH Medtech, is planning a listing on the Canadian Securities Exchange, the company announced Monday.
The listing is in conjunction with its reverse takeover of Prime Blockchain Inc, which was announced in June 2019.
New York-based RYAH, a wholly-owned subsidiary of PotBotics, focuses on predictive analytics in the global medical plant intake sector.
Its RYAH MediTech business produces a signature vaporizer that can precisely track dose and temperature and pairs with an app that uses artificial intelligence to help patients identify what treatments work best for them.
The submission of the listing statement will kick off a consulting phase by the CSE, with the company to prepare for a subsequent listing on the exchange.
RYAH and PotBotics CEO Gregory Wagner said that the submission represents a significant milestone for RYAH and its planned business combination with Prime.
“We’re grateful for the support that we’ve received throughout the process, and we’re excited to move towards our goal as a public company within a venue that attracts growth capital from investors, enabling RYAH to continue towards its goal of being a leader in clinical and healthcare data analytics,” Wagner said in a statement.
The company recently revealed that its dose-measuring dry herb inhaler passed key medical device compliance tests, clearing a path towards commercialization.
Contact Angela at email@example.com
Follow her on Twitter @AHarmantas